OLIGOPROGRESSIVE
Clinical trials for OLIGOPROGRESSIVE explained in plain language.
Never miss a new study
Get alerted when new OLIGOPROGRESSIVE trials appear
Sign up with your email to follow new studies for OLIGOPROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping stubborn cancer spots may extend life of current drug therapy
Disease control Recruiting nowThis study tests whether adding targeted radiation or heat-based ablation to ongoing drug therapy can control genitourinary cancers (prostate, bladder, or kidney) that have started growing in only a few new areas. Participants continue their current systemic treatment while recei…
Matched conditions: OLIGOPROGRESSIVE
Phase: NA • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New study: can targeted radiation keep lung cancer treatment working longer?
Disease control Recruiting nowThis study tests whether adding focused radiation or ablation to standard drug therapy can help people with lung cancer that has only a few new spots of growth. The goal is to see if this approach allows patients to stay on their current treatment longer without needing to switch…
Matched conditions: OLIGOPROGRESSIVE
Phase: NA • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Zapping resistant tumors may extend life of cancer drugs
Disease control Recruiting nowThis study tests whether adding a precise local treatment—like focused radiation or ablation—can help people whose cancer has a few new or growing spots while on standard therapy. Participants continue their usual medication while the resistant tumors are treated directly. The go…
Matched conditions: OLIGOPROGRESSIVE
Phase: NA • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radiation zaps resistant cancer spots, may extend immunotherapy success
Disease control Recruiting nowThis study tests whether precisely targeted radiation can control kidney cancer that has started growing in a few spots while a patient is on immunotherapy. About 30 adults with metastatic renal cell carcinoma will receive radiation to up to 5 progressing tumors and continue thei…
Matched conditions: OLIGOPROGRESSIVE
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC